Cargando…
In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disease characterized by disrupted memory, learning functions, reduced life expectancy, and locomotor dysfunction, as a result of the accumulation and aggregation of amyloid peptides that cause neuronal damage in neuronal circuits. In the current study, we...
Autores principales: | Uras, Giuseppe, Manca, Alessia, Zhang, Pengfei, Markus, Zsuzsa, Mack, Natalie, Allen, Stephanie, Bo, Marco, Xu, Shengtao, Xu, Jinyi, Georgiou, Marios, Zhu, Zheying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278008/ https://www.ncbi.nlm.nih.gov/pubmed/34276297 http://dx.doi.org/10.3389/fnins.2021.691222 |
Ejemplares similares
-
Development of p-Tau Differentiated Cell Model of Alzheimer’s Disease to Screen Novel Acetylcholinesterase Inhibitors
por: Uras, Giuseppe, et al.
Publicado: (2022) -
Novel and Potent Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease from Natural (±)-7,8-Dihydroxy-3-methyl-isochroman-4-one
por: Li, Xinnan, et al.
Publicado: (2022) -
Biochemical and cytochemical evidence indicates that coated vesicles in chick embryo myotubes contain newly synthesized acetylcholinesterase
Publicado: (1985) -
The interdependence of the Rho GTPases and apicobasal cell polarity
por: Mack, Natalie Ann, et al.
Publicado: (2014) -
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
por: Wu, Hongyu, et al.
Publicado: (2022)